Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Rev. int. androl. (Internet) ; 19(1): 1-8, ene.-mar. 2021. tab
Article in Portuguese | IBECS | ID: ibc-201664

ABSTRACT

OBJETIVOS: Determinação do impacto oncológico a nível afetivo/sexual assim como do grau de satisfação dos doentes quanto à informação recebida. Pretende‐se, adicionalmente, avaliar a importância da existência de uma abordagem especializada em sexologia durante o tratamento e seguimento oncológico. MÉTODOS: Estudo transversal que incluiu doentes oncológicos admitidos para consulta num serviço de radioterapia. Aplicação de um questionário e aferição de dados clínicos através do processo clínico. RESULTADOS: Amostra de 104 doentes, com uma média de 64,7 anos, em que a maioria (60,6%) refere ter disfunção sexual após o tratamento oncológico. Relativamente ao grau de informação, 62,5% encontram‐se satisfeitos quanto à informação fornecida pelos profissionais de saúde. Cerca de 2/3 dos doentes (66,4%) recorreriam a uma consulta de oncossexologia caso fossem referenciados pelo médico assistente. Não foram observadas diferenças estatisticamente significativas entre os subgrupos analisados relativamente ao impacto oncológico na sexualidade nem quanto à necessidade de uma abordagem especializada em sexologia. DISCUSSÃO: A abordagem da sexualidade nos doentes oncológicos engloba tanto o esclarecimento dos doentes como o tratamento das disfunções sexuais inerentes aos tratamentos. A existência de consultas de oncosexologia é uma forma de abordagem especializada, é do interesse da maioria dos nossos doentes. CONCLUSÕES: A sexualidade deve ser abordada com o doente oncológico desde o início da doença. Os cuidados especializados de oncossexologia são importantes ao constituírem uma via de redução do impacto oncológico na qualidade de vida


OBJECTIVES: Determination of the emotional and sexual impact after oncologic disease and patient's satisfaction regarding information provided by healthcare professionals. We also aim to evaluate the importance of sexology care during cancer treatment and follow‐up. METHODS: This is a cross‐sectional study including patients admitted for radiation therapy. A questionnaire and an assessment of clinical data were assessed. RESULTS: The study sample was composed by 104 patients. 60.6% had a negative impact on their sexual life after treatment and 62.5% were satisfied about the information given by healthcare professionals. About two thirds of the patients would accept sexology care during cancer treatment and/or follow‐up. After a sub‐group analysis, there were no statistically significant differences between groups regarding the prevalence of sexual dysfunction or needs for sexual care. DISCUSSION: There is a well‐known impact of cancer on sexuality since its diagnosis. Our patients feel themselves well informed about this by health professionals. Most of them would accept being referred to an oncosexology appointment. CONCLUSIONS: Sexuality must be discussed with cancer patients since their diagnosis. Oncosexuality care is necessary and desired by most patients as a mean for reduction of the cancer impact in their life quality


Subject(s)
Humans , Male , Middle Aged , Aged , Sexual Dysfunction, Physiological/epidemiology , Neoplasms/psychology , Sexual Dysfunctions, Psychological/epidemiology , Quality of Life/psychology , Sexual Dysfunction, Physiological/psychology , Cross-Sectional Studies , Surveys and Questionnaires
2.
Rev Int Androl ; 19(1): 1-8, 2021.
Article in Portuguese | MEDLINE | ID: mdl-31630968

ABSTRACT

OBJECTIVES: Determination of the emotional and sexual impact after oncologic disease and patient's satisfaction regarding information provided by healthcare professionals. We also aim to evaluate the importance of sexology care during cancer treatment and follow-up. METHODS: This is a cross-sectional study including patients admitted for radiation therapy. A questionnaire and an assessment of clinical data were assessed. RESULTS: The study sample was composed by 104 patients. 60.6% had a negative impact on their sexual life after treatment and 62.5% were satisfied about the information given by healthcare professionals. About two thirds of the patients would accept sexology care during cancer treatment and/or follow-up. After a sub-group analysis, there were no statistically significant differences between groups regarding the prevalence of sexual dysfunction or needs for sexual care. DISCUSSION: There is a well-known impact of cancer on sexuality since its diagnosis. Our patients feel themselves well informed about this by health professionals. Most of them would accept being referred to an oncosexology appointment. CONCLUSIONS: Sexuality must be discussed with cancer patients since their diagnosis. Oncosexuality care is necessary and desired by most patients as a mean for reduction of the cancer impact in their life quality.


Subject(s)
Neoplasms , Sexology , Sexual Dysfunction, Physiological , Cross-Sectional Studies , Humans , Medical Oncology , Neoplasms/complications , Neoplasms/therapy , Sexual Dysfunction, Physiological/epidemiology , Sexual Dysfunction, Physiological/etiology , Sexuality
3.
J Appl Oral Sci ; 23(5): 497-507, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26537721

ABSTRACT

UNLABELLED: The value of aesthetic dentistry has precipitated several developments in the investigation of dental materials related to this field. The free marketing of these products is a problem and it is subject to various interpretations regarding its legality. There are several techniques for tooth whitening, the most used one being the external bleaching. It is the later version of such technique that poses the greatest danger of ingesting the product. The present study analysed the systemic effect of these products when they are swallowed. OBJECTIVE: This experimental study aimed to observe the effects of a tooth whitening product, whose active agent is 6% hydrogen peroxide, on the gastric mucosa of healthy and non-tumour gastric pathology animals. MATERIAL AND METHODS: Fifty Wistar-Han rats were used and then distributed into 5 groups, one for control and four test groups in which the bleaching product was administered in animals with and without non-tumour gastric pathology (induced by the administration of 1 sample of 50% ethanol and 5% of drinking water during 6 days) at different times of study by gavage. There was a decrease in body weight in animals of groups handled during the study period, which was most pronounced in IV and VA groups. Changes in spleen weight relative to body weight revealed no statistically significant changes. An analysis of the frequency was performed on the results of macroscopic observation of the gastric mucosa. RESULTS: The gastric mucosa revealed lesions in all manipulated groups, being more frequent in groups III and IV. It appears that there is a synergism when using hydrogen peroxide and 50% ethanol in the same group. CONCLUSION: Therefore, it seems that there are some signs of toxicity 3 to 4 days after administration of 6% hydrogen peroxide. The prescription of these therapies must be controlled by the clinician and the risks must be minimized.


Subject(s)
Gastric Mucosa/drug effects , Hydrogen Peroxide/toxicity , Tooth Bleaching Agents/toxicity , Tooth Bleaching/adverse effects , Animals , Body Weight , Ethanol/toxicity , Gastric Mucosa/pathology , Organ Size , Rats, Wistar , Spleen/drug effects , Spleen/pathology , Time Factors
4.
J. appl. oral sci ; 23(5): 497-507, Sept.-Oct. 2015. tab, graf
Article in English | LILACS, BBO - Dentistry | ID: lil-764156

ABSTRACT

The value of aesthetic dentistry has precipitated several developments in the investigation of dental materials related to this field. The free marketing of these products is a problem and it is subject to various interpretations regarding its legality. There are several techniques for tooth whitening, the most used one being the external bleaching. It is the later version of such technique that poses the greatest danger of ingesting the product. The present study analysed the systemic effect of these products when they are swallowed.Objective This experimental study aimed to observe the effects of a tooth whitening product, whose active agent is 6% hydrogen peroxide, on the gastric mucosa of healthy and non-tumour gastric pathology animals.Material and Methods Fifty Wistar-Han rats were used and then distributed into 5 groups, one for control and four test groups in which the bleaching product was administered in animals with and without non-tumour gastric pathology (induced by the administration of 1 sample of 50% ethanol and 5% of drinking water during 6 days) at different times of study by gavage. There was a decrease in body weight in animals of groups handled during the study period, which was most pronounced in IV and VA groups. Changes in spleen weight relative to body weight revealed no statistically significant changes. An analysis of the frequency was performed on the results of macroscopic observation of the gastric mucosa.Results The gastric mucosa revealed lesions in all manipulated groups, being more frequent in groups III and IV. It appears that there is a synergism when using hydrogen peroxide and 50% ethanol in the same group.Conclusion Therefore, it seems that there are some signs of toxicity 3 to 4 days after administration of 6% hydrogen peroxide. The prescription of these therapies must be controlled by the clinician and the risks must be minimized.


Subject(s)
Animals , Gastric Mucosa/drug effects , Hydrogen Peroxide/toxicity , Tooth Bleaching Agents/toxicity , Tooth Bleaching/adverse effects , Body Weight , Ethanol/toxicity , Gastric Mucosa/pathology , Organ Size , Rats, Wistar , Spleen/drug effects , Spleen/pathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...